Status:
COMPLETED
PHAGE Study: Bacteriophages as Novel Prebiotics
Lead Sponsor:
Colorado State University
Collaborating Sponsors:
George Mason University
Metabiomics Corp
Conditions:
Gastrointestinal Disorder, Functional
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The PHAGE study is designed to determine if a commercial prebiotic product can change the composition of bacteria in the gut for improved intestinal health. A prebiotic is defined as an indigestible d...
Detailed Description
The goal of this study is to see if consumption of PreforPro, a commercially available prebiotic dietary supplement consisting of a mixture of bacteriophages, improves gut bacteria profiles in individ...
Eligibility Criteria
Inclusion
- Healthy adults
- 18-65 years old
- Mild to moderate GI distress (self-assessed)
Exclusion
- Pregnant or breastfeeding
- Diagnosed GI disease (Celiac, peptic ulcer, ulcerative colitis, Crohn's disease, cancer, or other gastrointestinal or metabolic diseases)
- Antibiotic use in the past 2 months
- Use of NSAIDS, statins, metformin, and other drugs known to modify the gut microbiota
- BMI less than 18.0 or greater than 35.0
Key Trial Info
Start Date :
October 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2017
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT03269617
Start Date
October 1 2016
End Date
May 30 2017
Last Update
April 4 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.